Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences

NEW YORK – Foundation Medicine said on Wednesday that it has signed a non-exclusive licensing agreement with TwinStrand Biosciences for a sequencing-based technology for rare mutation detection.

The agreement covers two foundational patent families from TwinStrand, a University of Washington spinout based in Seattle. 

The company's duplex sequencing technology independently tracks both strands of DNA molecules and then compares the paired sequences to eliminate errors. It can be used for residual cancer detection and genetic toxicology, among other applications. 

"We look forward to expanding this agreement with TwinStrand to explore additional areas for future collaboration," Foundation Medicine CEO Cindy Perettie said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.